Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-01-22

Clinical Trial Update: SPARK- a Digital Platform to Improve Self-management of Gestational Diabetes [NA]

View source ↗

Summary

SPARK is a digital platform trial to improve self-management of gestational diabetes and is currently recruiting at Karolinska Institutet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Karolinska Institutet | Conditions: Gestational Diabetes Mellitus | NA | Status: RECRUITING